Page saved! You can go back to this later in your Diabetes and Me Close

Tracking Treg cell changes in type 1 diabetes

September 2025
November 2026
London, Cardiff
University College London
Treg-sparing co-stimulation blockade: testing a novel method for monitoring an immunosuppression strategy in people with Type 1 diabetes.

Researchers at University College London are looking for people aged 18-50 who were diagnosed with type 1 diabetes in the last five years to take part in a study of the immune system responsible for destruction of insulin-producing cells. They hope that this will help develop future treatments for type 1 diabetes.

The study will include administration of drugs (via small tube inserted in the vein and under the skin) and giving blood and lymph node samples (via a small needle similar to the one used for standard blood tests).

Each participant will receive a compensation as a token of thanks for their time and effort given in taking part, as well as any travel expenses incurred.

For further information please contact:

Dr Sarah Ali, Rajeshwar Ramkhelawon (Raj) at the Royal Free London NHS Foundation Trust (Call Mon-Fri 9am to 5pm on 0207 794 0500 ext 39825 or email at rajeshwar.ramkhelawon@nhs.net

This study is part of the Type 1 Diabetes Grand Challenge.

Back to Top
Brand Icons/Telephone check - FontAwesome icons/tick icons/uk